Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice

Fig. 4

Effects of rivaroxaban on human EPC tube formation in vitro. An in vitro angiogenesis assay for EPCs used ECMatrix gel. Cells were stained with crystal violet, and the averages of the total area of complete tubes formed by cells were compared using computer software. Data are the mean ± SEM. (*P < 0.05 compared with control, # P < 0.05 compared with HG group, n = 4 for each experiment)

Back to article page